Company profile for Creyon Bio

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Creyon Bio is taking an engineering approach to creating new oligonucleotide-based medicines (OBMs). We bring together insights from modern biology, genomics, pharmacology, biophysics, and chemistry with the speed and predictive power of machine learning and AI. Creyon’s advanced machine learning and AI-backed platform maps sequence and foundational biophysical properties of existing and novel OBM chemistry to build accurate...
Creyon Bio is taking an engineering approach to creating new oligonucleotide-based medicines (OBMs). We bring together insights from modern biology, genomics, pharmacology, biophysics, and chemistry with the speed and predictive power of machine learning and AI. Creyon’s advanced machine learning and AI-backed platform maps sequence and foundational biophysical properties of existing and novel OBM chemistry to build accurate predictive models of safety and efficacy. The platform works by identifying the design rules and engineering principles for OBMs.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
3210 Merryfield Row San Diego, CA 92121
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.fiercebiotech.com/biotech/eli-lilly-pens-creyon-bio-ai-oligonucleotide-pact-1b-biobucks-table

FIERCE BIOTECH
30 Apr 2025

https://www.businesswire.com/news/home/20250423021563/en/Creyon-Bio-Appoints-Industry-Leader-Serge-Messerlian-as-CEO-Leveraging-Decades-of-Company-Building-and-Strategic-Collaborations

BUSINESSWIRE
23 Apr 2025
Creyon Bio Appoints New Board Members
Creyon Bio Appoints New Board Members

09 Sep 2024

// GLOBENEWSWIRE

https://www.globenewswire.com/news-release/2024/09/09/2942793/0/en/Creyon-Bio-Appoints-Venture-Capitalists-Serge-Messerlian-and-Shaquille-Vayda-to-Board-of-Directors.html

GLOBENEWSWIRE
09 Sep 2024

https://www.globenewswire.com/news-release/2024/09/04/2940482/0/en/Creyon-Bio-Granted-Second-U-S-Patent-for-AI-Machine-Learning-Enabled-Oligonucleotide-Based-Medicine-Engineering-Platform.html

GLOBENEWSWIRE
04 Sep 2024

https://www.globenewswire.com/news-release/2024/05/07/2876701/0/en/Creyon-Bio-to-Present-Clinical-Data-on-Rapid-AI-Enabled-Engineering-of-Oligonucleotide-Based-Medicines-at-the-American-Society-of-Gene-Cell-Therapy-ASGCT-27th-Annual-Meeting.html

GLOBENEWSWIRE
07 May 2024

https://www.prnewswire.com/news-releases/david-dimmock-md-joins-creyon-bio-as-chief-medical-officer-301509592.html

PRNEWSWIRE
24 Mar 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty